Assembly Biosciences (ASMB) Enterprise Value (2016 - 2025)
Assembly Biosciences (ASMB) has 11 years of Enterprise Value data on record, last reported at -$22.5 million in Q3 2025.
- For Q3 2025, Enterprise Value rose 20.8% year-over-year to -$22.5 million; the TTM value through Sep 2025 reached -$22.5 million, up 20.8%, while the annual FY2024 figure was -$112.1 million, 13.95% up from the prior year.
- Enterprise Value reached -$22.5 million in Q3 2025 per ASMB's latest filing, up from -$75.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$18.1 million in Q1 2024 and bottomed at -$214.9 million in Q1 2021.
- Average Enterprise Value over 5 years is -$81.3 million, with a median of -$73.0 million recorded in 2023.
- Peak YoY movement for Enterprise Value: plummeted 407.69% in 2021, then soared 78.37% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$146.6 million in 2021, then skyrocketed by 37.52% to -$91.6 million in 2022, then plummeted by 42.18% to -$130.2 million in 2023, then grew by 13.95% to -$112.1 million in 2024, then soared by 79.89% to -$22.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$22.5 million in Q3 2025, -$75.0 million in Q2 2025, and -$91.0 million in Q1 2025.